NFL Agent Raises Concerns Over Jalen Hurts’ Medical Situation

Renowned NFL agent Leigh Steinberg recently shared his views on Jalen Hurts’ blood clot health issue, predicting a significant impact on the league and its quarterback agents. He noted that if a quarterback he represented faced a similar situation, he would actively reach out to team doctors for answers. Steinberg emphasized the need for medical experts to assess whether the Philadelphia Eagles handled Hurts’ care properly.

Steinberg explained to OutKick that the mention of a blood clot is a serious concern. He would have contacted the Eagles medical staff immediately upon learning of such a condition. “Blood clot is a red flag,” he asserted.

Jalen Hurts is expected to sit out the remainder of the season after discovering deep vein thrombosis and bilateral pulmonary emboli—blood clots impacting both lungs. On October 25, the NFL and NFL Players Association announced a joint review to address the issue, responding to the union’s request for an investigation.

Steinberg highlighted the crucial role an agent plays in ensuring the health and safety of players. He stressed that agents must prioritize players’ well-being over football pressures. He expressed confidence in Hurts’ agent, Nicole Lynn, affirming her diligence and professionalism in handling her client’s situation.

The controversy began when Hurts was cleared to play against the Jacksonville Jaguars in London on October 11, despite an ultrasound identifying a superficial clot in his left calf. Hurts first reported the injury on October 8, following an October 4 game. After an October 10 ultrasound in London, doctors allowed him to play, believing that mobility was important. A subsequent ultrasound on October 14 found clot movement, leading to Hurts being placed on injured reserve on October 17.

Steinberg questioned whether playing in London was appropriate, emphasizing that the determination of medical decisions requires expertise in blood clot diagnosis. He expressed confidence in Eagles owner Jeffrey Lurie and general manager Howie Roseman’s commitment to player health, acknowledging that Hurts’ condition might have evolved irrespective of initial care.

The NFL’s medical chief, Allen Sills, expressed full confidence in the Eagles’ medical staff. Meanwhile, the NFLPA called for a comprehensive investigation before conclusions were drawn. Reports indicated that the investigation’s process and specifics were under discussion.

While Hurts’ condition is serious, he has been described as clinically stable by the Eagles and Lynn, expecting a complete recovery. His treatment with blood thinners prevents participation in contact sports, but he continues conditioning with the team.

Steinberg believes the progression from a minor to a life-threatening health issue will alert the league. He highlighted his ongoing efforts on player health, particularly concussions, through his foundation dedicated to understanding and preventing traumatic brain injuries.

The situation also carries significant football implications. Steinberg noted the challenges teams face when franchise quarterbacks, like Hurts, signed on five-year, $255 million contracts, become unavailable. Philadelphia has turned to Tanner McKee, a sixth-round pick from Stanford, following Hurts’ exit.

Steinberg pointed out the talent disparity between Hurts and McKee as a challenge, impacting the Eagles’ competitiveness. He emphasized long-term health as the primary concern, advocating for safeguarding players from severe health issues.